By David Haas
With no definitive cure for mesothelioma, cancer patients have limited options, and enter clinical trials with the hope of increasing their chances of survival and managing their pain.
Mesothelioma is a rare form of cancer that primarily affects the lungs. Due to its prolonged latency period of 10 to 50 years, symptoms often do not present themselves until the later stages of a patient’s life. It is paramount that this cancer is detected early on for the best possible outcome, however, this is often not the case. By the time this cancer is diagnosed, it may have already metastasized, or developed into a more aggressive stage.
With treatment options minimal for patients whose mesothelioma has advanced, the focus shifts towards methods of relieving pain, increasing quality of life through comfort, and achieving remission.